Chinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.The U.S. Food and Drug Administration is work…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreWegovy, Saxenda Help Folks Lose Pounds They Regained After Weight-Loss Surgery
MONDAY, June 5, 2023 (HealthDay News) — When people regained weight after obesity surgery, it wasn’t entirely clear what to do next. Now, it appears the weight-loss medications Wegovy and Saxenda can help.Both work by controlling appetite and satiety…
Learn MoreMedicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With Limits
FRIDAY, June 2, 2023 (HealthDay News) — Medicare will soon cover a new class of drugs for Alzheimer disease if they receive full approval from the U.S. Food and Drug Administration, with some key limits.Along with full approval, drug makers will also…
Learn MoreDrug Might Help Slow Nearsightedness in Kids
FRIDAY, June 2, 2023 (HealthDay News) — There is no cure for nearsightedness, but medicated eye drops can slow down its progression in children, a new trial finds.The study tested the effects of eye drops containing a very low dose of the drug atropi…
Learn MoreIntranasal Ketamine Seems Effective for Refractory Chronic Migraine
FRIDAY, June 2, 2023 (HealthDay News) — Intranasal ketamine seems effective for refractory chronic migraine, with about half of patients reporting it as very effective, according to a study published online May 30 in Regional Anesthesia & Pain Medici…
Learn MoreIntranasal Ketamine Seems Effective for Refractory Chronic Migraine
FRIDAY, June 2, 2023 (HealthDay News) — Intranasal ketamine seems effective for refractory chronic migraine, with about half of patients reporting it as very effective, according to a study published online May 30 in Regional Anesthesia & Pain Medici…
Learn More